• FirefoxUpgrade to the new Firefox »
  •  Dow Down0.79% Nasdaq Up0.16%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NGM
    9.59 Down 0.23(2.34%) Jan 23, 4:00PM EST
    |After Hours : 9.59 0.00 (0.00%) Jan 23, 4:31PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Net Income (27,901) (18,109) (27,585) (33,059)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation570  1,355  886  663  
    Adjustments To Net Income4,976  6,278  5,080  4,756  
    Changes In Accounts Receivables5,314  5,547  (6,299)2,704  
    Changes In Liabilities79,645  (25,809)(6,387)(6,688)
    Changes In Inventories -   -   -   -  
    Changes In Other Operating Activities(1,370)(1,914)3,087  3,488  
    Total Cash Flow From Operating Activities 61,097   (32,833) (31,387) (27,425)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(1,731)(1,545)(1,438)(796)
    Investments(38,834)42,131  32,502  (13,264)
    Other Cash flows from Investing Activities -   -   -  (3)
    Total Cash Flows From Investing Activities (40,565) 40,586   31,064   (14,063)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid(7) -   -   -  
    Sale Purchase of Stock1,645  2,802  2,134  481  
    Net Borrowings400  300   -  642  
    Other Cash Flows from Financing Activities2  (1) -   -  
    Total Cash Flows From Financing Activities 2,040   3,101   2,134   1,123  
    Effect Of Exchange Rate Changes -   -   -   -  
    Change In Cash and Cash Equivalents 22,572   10,854   1,811   (40,365)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.